

Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder
National Autism Association calls 2006 Pediatrics study fatally flawed
Rita Shreffler
March 7, 2007
Chicago
- New findings presented yesterday at a National Autism Association meeting bolster
claims that vaccines may play a role in the development of autism spectrum disorders.
David Ayoub, MD presented data suggesting a correlation between mercury-containing
vaccines and rates of pervasive developmental disorder (PDD), a form of autism,
in Montreal. The peak rate of one in 87 children diagnosed with PDD occurred following
the period of greatest exposure to the mercury-based vaccine preservative thimerosal.
A flattening of the rates studied is now emerging as mercury-containing vaccines
have been gradually eliminated from the routine schedule.
This new data
points out flaws in a 2006 study published in the journal Pediatrics by Eric Fombonne,
MD, et al, which found PDD rates continued to increase even when rates of MMR
vaccination and use of mercury-containing vaccines decreased. The study population
consisted of a single Montreal school board that was an Autism Center of Excellence,
suggesting an over-ascertainment of regional diagnoses. Dr. Ayoub and co-authors
Monica Ruscitti, BA, and F. Edward Yazbak, MD broadened the data to include all
five Montreal school boards.
The earlier study also reported PDD rates
in children from Montreal, but MMR coverage data was taken from Quebec City located
265km from Montreal. The researchers confirmed MMR coverage rates actually increased
in Montreal along with PDD, noting a sharper rise in rates after the number of
required MMR shots doubled.
The Pediatrics paper claimed there was no exposure
to mercury from vaccines post-1996 although several mercury-containing vaccines
were administered well beyond 1996. “It’s irresponsible that such
flawed data was published in a medical journal. This new information confirms
a relationship between vaccines and autism that can’t be explained by better
diagnosing or changing diagnostic criteria,” said Karen McDonough, NAA-Chicago
president.
Drs. Ayoub and Yazbak detailed the Fombonne study flaws in letters
to Pediatrics which the journal declined to publish. Editor Jerold F. Lucey, MD
stated in a reply, “I believe the evidence of no link between MMR and Autism
is sufficient. It's not worth publishing more on this subject.
This dismissal
of legitimate concerns regarding data affecting those suffering with autism is
a disgrace,commented Ms. McDonough.




View all Audio files
You are about to visit a third-party site. We are not responsible for the information contained on third-party sites. Do you wish to continue?